Home/Investors/Private Angel Investors

Private Angel Investors

Biotech Investor · 4 portfolio companies

Portfolio

4

Focus Areas

9

Top Stage

Pre-clinical

Investment Focus

Cystic Fibrosis Usher Syndrome Metabolic Dysfunction-associated Steatohepatitis Alcoholic Liver Disease Neurology Inflammation Oncology Rare Genetic Diseases Infectious Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
GeneToBe	Pre-clinical	—	Cystic Fibrosis, Usher Syndrome
ChromaTwist	Commercial	—	—
Canurta	preclinical	—	Neurology, Inflammation
AID Genomics	commercial	—	Oncology, Rare Genetic Diseases

Frequent Co-Investors

Innovate UK1 shared Angelgroups (SEI Investment)1 shared Non‑dilutive government grants1 shared Israeli Ministry of Health (government contract)1 shared